Condition
MDS/AML clinical trials and research
As of November 12, 2026, Find a Trial lists 2 MDS/AML clinical trials that are recruiting, at sites in 3 countries (most in Austria (1), Germany (1), United States (1)). By phase: Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
Ropeginterferon Alfa-2b added to azacitidine in TP53-mutant MDS/AML
This study tests whether adding ropeginterferon alfa-2b to azacitidine helps people with TP53-mutant MDS/AML, by finding an effective dose and looking for tumor response.
-
Registry of patient characteristics and outcomes in acute myeloid leukemia
This study is gathering information from adults with newly diagnosed or returning acute myeloid leukemia to see how different factors affect their treatment and survival over time.
Related topics
Quick answers
How many MDS/AML clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Austria (1 trial), Germany (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.